Shares of KP Tissue Inc. (TSE:KPT - Get Free Report) hit a new 52-week high on Monday . The stock traded as high as C$9.23 and last traded at C$9.25, with a volume of 20645 shares. The stock had previously closed at C$9.17.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on KPT shares. National Bankshares boosted their price objective on KP Tissue from C$8.50 to C$9.50 and gave the company a "sector perform" rating in a research report on Thursday, May 22nd. TD Securities increased their price objective on KP Tissue from C$8.00 to C$9.00 and gave the stock a "hold" rating in a research note on Thursday, May 22nd. Finally, Desjardins lifted their target price on shares of KP Tissue from C$8.50 to C$9.50 and gave the company a "hold" rating in a research note on Thursday, May 22nd.
Get Our Latest Analysis on KPT
KP Tissue Stock Performance
The company has a market cap of C$91.65 million, a price-to-earnings ratio of 14.36, a P/E/G ratio of -0.88 and a beta of 0.37. The stock has a 50 day moving average price of C$8.55 and a two-hundred day moving average price of C$8.22.
KP Tissue Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 15th will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 7.85%. The ex-dividend date of this dividend is Monday, June 30th. KP Tissue's dividend payout ratio (DPR) is 112.73%.
About KP Tissue
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Featured Articles
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
